Calidi Biotherapeutics, Inc. (CLDI)

NYSEAMERICAN: CLDI · Real-Time Price · USD

0.5571

-0.0089 (-1.57%)

Apr 1, 2025, 4:00 PM EST - Market closed

Calidi Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 1, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11	54	100	282	-
Market Cap Growth	-90.56%	-46.70%	-64.38%	-	-
Enterprise Value	8	53	121	-	-
Last Close Price	0.56	15.10	101.70	98.10	-
PS Ratio	-	2232.43	628.15	-
PB Ratio	5.55	-6.50	-2.46	-12.47	-
EV/Sales Ratio	-	2683.59	-	-
Debt / Equity Ratio	-0.92	-0.88	-0.15	-0.23	-0.87
Asset Turnover	-	-	0.02	0.17	-
Quick Ratio	0.16	0.19	0.01	0.08	0.05
Current Ratio	0.19	0.42	0.02	0.11	0.06
Return on Assets (ROA)	-136.52%	-287.25%	-482.80%	-229.02%	-
Earnings Yield	-221.30%	-54.56%	-25.31%	-3.88%	-
FCF Yield	-181.57%	-51.48%	-13.58%	-2.83%	-
Buyback Yield / Dilution	-402.94%	-98.55%	56.93%	-15.26%	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q